European Study Finds the Abbott CardioMEMS Sensor Results in Improved Quality of Life and 44% Reduction in Heart Failure Hospitalizations
(Source: Abbott.com)
Source: Abbott.com - May 24, 2023 Category: Pharmaceuticals Source Type: news
Abbott Unveils Late-Breaking Data Showing the World's First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints
(Source: Abbott.com)
Source: Abbott.com - May 20, 2023 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA Approval for TactiFlex ™ Ablation Catheter for Treatment of Abnormal Heart Rhythm
(Source: Abbott.com)
Source: Abbott.com - May 19, 2023 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA Clearance for Assert-IQ ™ Insertable Cardiac Monitor to Help Doctors Monitor People's Heart Rhythms Long-Term
(Source: Abbott.com)
Source: Abbott.com - May 18, 2023 Category: Pharmaceuticals Source Type: news
New Late-Breaking Data Reinforce the Benefits of Abbott's TriClip ™ Device for People With Tricuspid Valve Disease
Data presented at EuroPCR 2023 build on prior study results demonstrating TriClip is a safe and effective therapy to treat leaky tricuspid valves (Source: Abbott.com)
Source: Abbott.com - May 17, 2023 Category: Pharmaceuticals Source Type: news
Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options
(Source: Abbott.com)
Source: Abbott.com - May 16, 2023 Category: Pharmaceuticals Source Type: news
People With Chronic Pain Who Use Abbott ’s Eterna™ Spinal Cord Stimulator Now Have Expanded MRI Options
The Eterna ™ spinal cord stimulation (SCS) system is FDA approved for wider access to scans, allowing for more options for people in need of imaging (Source: Abbott.com)
Source: Abbott.com - May 11, 2023 Category: Pharmaceuticals Source Type: news
Abbott Announces New Partnerships and Programs to Advance its Diversity in Clinical Trials Initiative
(Source: Abbott.com)
Source: Abbott.com - May 11, 2023 Category: Pharmaceuticals Source Type: news
Abbott Completes Acquisition of Cardiovascular Systems, Inc.
(Source: Abbott.com)
Source: Abbott.com - April 27, 2023 Category: Pharmaceuticals Source Type: news
Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
(Source: Abbott.com)
Source: Abbott.com - April 25, 2023 Category: Pharmaceuticals Source Type: news
Abbott and New Global Consortium Partnership Address Viral Outbreaks Caused by Climate Change
(Source: Abbott.com)
Source: Abbott.com - April 20, 2023 Category: Pharmaceuticals Source Type: news
Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business
(Source: Abbott.com)
Source: Abbott.com - April 19, 2023 Category: Pharmaceuticals Source Type: news
Abbott's FreeStyle Libre ® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries
(Source: Abbott.com)
Source: Abbott.com - April 17, 2023 Category: Pharmaceuticals Source Type: news
FDA Clears Reader for Abbott's FreeStyle Libre ® 3 System
(Source: Abbott.com)
Source: Abbott.com - April 14, 2023 Category: Pharmaceuticals Source Type: news
Abbott Issues Safety Notification for FreeStyle Libre ® Family of Readers in the U.S.
(Source: Abbott.com)
Source: Abbott.com - April 3, 2023 Category: Pharmaceuticals Source Type: news
